"H2 npat at mid point up 33% on pcp, HY was up 7%. "
@CaptainBarnacles,
I'd be a bit wary of using the NPAT line as a measure of KME's underlying financial performance. The reason I say that is because the JH2017 result was boosted by a very light tax rate (12.8%), although this was partly offset of a doubling in the D&A charge on pcp (from $230k to $470k).
The cleaner picture, I think, is obtained at looking at the EBITDA line, where the first half was up 22% (to $1.448m in DH2017 from DH2016's $1.190m), and the mid-point of today's full-year EBITDA guidance implies a 42% increase in the second-half (to $2.05m, from $1.445m in JH2017).
.
Ann: Earnings Update June 2018, page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add KME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.015(3.41%) |
Mkt cap ! $27.00M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 45.5¢ | 44.0¢ | $12.94K | 28.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13805 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 2770 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| KME (ASX) Chart |
